Second-generation Amplatzer Vascular Plug (AVP) for the treatment of subsequent subclavian backflow type II endoleak after TEVAR.
Since its approval as an occlusive device in the peripheral vasculature in 2004, the first-generation Amplatzer Vascular Plug (AVP; AGA Medical, Golden Valley, MN, USA) has already become a therapeutic alternative to coil embolization in dedicated cases. Here, we present for the first time, a case of type II endoleak from the left subclavian artery after thoracic stent-graft placement successfully treated with a second-generation AVP.